EN 
FR 
Linearis Ventures, the responsible AI health fund, provides access to capital and disease signatures in Cancer, AMR and Diabetes to facilitate diagnosis, monitoring treatment and improve drug discovery for our partners.
People
Improving accessibility to early diagnosis and personalized for high burden diseases
Planet
Eco-Friendly AI & Laboratories
Prosperity
Government & Foundation Infectious Diseases Diabetes and Cancer Solutions
Primary Purpose
Impact on Patient Lives
Prevention
Fast
Accurate
Affordable
Early Diagnostics
Personalized treatment
Predictive response
Drug Discovery
In Silico – Vitro – Vivo Feedback loop & optimization for curative treatments
Accessible & Responsible
Accessible Societal benefits for cancer, diabetes and AMR aligned with financial incentives